InvenSense, Inc. (NYSE:INVN) announced results for its first quarter of fiscal year 2016, ended June 28, 2015. Net revenue for the first quarter of fiscal 2016 was $106.3 million, up 7 percent from $99.3 million for the fourth quarter of fiscal 2015, and up 59 percent from $66.7 million for the first quarter of fiscal 2015. InvenSense, Inc. (NYSE:INVN) belongs to Technology sector. Its net profit margin is -0.30% and weekly performance is -8.95%. On last trading day company shares ended up $11.70. InvenSense, Inc. (NYSE:INVN) distance from 50-day simple moving average (SMA50) is -18.12%.
Cambrex Corp. (NYSE:CBM) on Thursday reported second-quarter earnings of $19.7 million. The East Rutherford, New Jersey-based company said it had net income of 61 cents per share. Earnings, adjusted for one-time gains and costs, came to 63 cents per share. Cambrex Corporation. (NYSE:CBM) shares advanced 3.30% in last trading session and ended the day at $53.82. CBM Gross Margin is 37.70% and its return on assets is 13.40%. Cambrex Corporation. (NYSE:CBM) quarterly performance is 45.38%.
On 05 August, Companhia Energetica Minas Gerais (ADR) (NYSE:CIG) shares decreased -4.30% and was closed at $2.67. CIG EPS growth in last 5 year was 7.90%. Companhia Energetica Minas Gerais (ADR) (NYSE:CIG) year to date (YTD) performance is -43.72%.
Pointer Telocation Ltd. (NASDAQ:PNTR), announced that it will release its financial results for the second quarter of 2015 on Thursday, August 13th, 2015. Pointer Telocation’s management will host a conference call that same day, at 9:30 ET, 16:30 Israel time. On the call, management will review and discuss the results. Pointer Telocation Ltd. (NASDAQ:PNTR) ended the last trading day at $6.51. Company weekly volatility is calculated as 5.25% and price to cash ratio as 6.02. Pointer Telocation Ltd. (NASDAQ:PNTR) showed a weekly performance of -1.81%.
Infinity Pharmaceuticals Inc. (NASDAQ:INFI) on Thursday reported a loss of $38.4 million in its second quarter. On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 78 cents. Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) shares decreased -0.23% in last trading session and ended the day at $8.80. INFI return on assets is -63.10%. Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) quarterly performance is -27.63%.